The FDA has approved Novartis‘ Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an ...

Teva announced the launch of Amlodipine, Valsartan, and Hydrochlorothiazide Tablets, the generic version of Novartis‘ Exforge HCT. Exforge HCT contains amlodipine, a calcium channel blocker, valsartan ...

The first fixed-dose combination pill containing 3 drugs has been approved for use in the United States by the US Food and Drug Administration (FDA). Exforge HCT®, which is marketed by Novartis, ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Exforge HCT contains the active ingredients Amlodipine Besilate, ...

With Teva being the first to file, the company will enjoy 180 days of marketing exclusivity. As per IMS data, Exforge HCT tablets recorded annual sales of approximately $158 million in the U.S. as of ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a hypertension drug that combines a calcium antagonist, an angiotensin II receptor ...

EAST HANOVER, N.J., Aug. 4 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge ...

Novartis has received a major boost in the USA after regulators there gave their backing to two of the Swiss major’s combination high blood-pressure drugs which can now be used as first-line ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. AMLODIPINE/VALSARTAN/HCT NOVARTIS contains the active ingredients ...

Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies[1] Up to 80% of patients may need multiple medications to help them reach blood ...

Teva Pharmaceutical Industries Limited ( TEVA) has launched its generic version of Novartis' ( NVS) Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the U.S. Exforge HCT is approved ...

The FINANCIAL — The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT (valsartan and hydrochlorothiazide) and Exforge (amlodipine and valsartan), ...